{{Rsnum
|rsid=11583200
|Gene=ELAVL4
|Chromosome=1
|position=50094148
|Orientation=plus
|GMAF=0.3898
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ELAVL4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.3 | 44.6 | 41.1
| HCB | 86.7 | 11.9 | 1.5
| JPT | 67.3 | 29.1 | 3.6
| YRI | 61.0 | 32.9 | 6.2
| ASW | 57.9 | 35.1 | 7.0
| CHB | 86.7 | 11.9 | 1.5
| CHD | 86.0 | 14.0 | 0.0
| GIH | 33.7 | 53.5 | 12.9
| LWK | 56.5 | 38.0 | 5.6
| MEX | 31.6 | 49.1 | 19.3
| MKK | 38.5 | 49.4 | 12.2
| TSI | 10.8 | 45.1 | 44.1
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11583200
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363812
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11583200
|overall_frequency_n=56
|overall_frequency_d=128
|overall_frequency=0.4375
|n_genomes=35
|n_genomes_annotated=0
|n_haplomes=51
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}